| 1 | Penile Neoplasms | 39.7% |
| 2 | Prostatic Neoplasms | 39.7% |
| 3 | Parathyroid Neoplasms | 34.6% |
| 4 | Thyroid Neoplasm | 34.6% |
| 5 | Thyroid carcinoma | 34.6% |
| 6 | Adrenal Gland Neoplasms | 30.6% |
| 7 | Prostatic Neoplasms, Castration-Resistant | 29.7% |
| 8 | Multiple Endocrine Neoplasia | 27.6% |
| 9 | Pancreatic Neoplasm | 27.2% |
| 10 | ovarian neoplasm | 25.8% |
| 11 | Thyroid Nodule | 24.6% |
| 12 | Pituitary Adenoma | 21.4% |
| 13 | Pituitary Neoplasms | 21.4% |
| 14 | Urologic Neoplasms | 21.3% |
| 15 | Orchitis | 20.9% |
| 16 | Cryptorchidism | 20.9% |
| 17 | Prolactinoma | 19.2% |
| 18 | Growth Hormone-Secreting Pituitary Adenoma | 19.2% |
| 19 | Multiple Endocrine Neoplasia Type 1 | 19% |
| 20 | granulosa cell tumor | 18.6% |
| 21 | Carcinoma, Ovarian Epithelial | 18.6% |
| 22 | Carcinoma, Pancreatic Ductal | 18.1% |
| 23 | Adrenocortical carcinoma | 17.9% |
| 24 | Abdominal Neoplasms | 15.9% |
| 25 | Head and Neck Neoplasms | 15.9% |
| 26 | Soft Tissue Neoplasms | 15.9% |
| 27 | Thoracic Neoplasms | 15.9% |
| 28 | Nelson Syndrome | 15.8% |
| 29 | insulinoma | 15.3% |
| 30 | Gastrinoma | 15.1% |
| 31 | Glucagonoma | 15.1% |
| 32 | Vipoma | 14.8% |
| 33 | Digestive System Neoplasms | 14.3% |
| 34 | Eye Neoplasms | 14.3% |
| 35 | Nervous System Neoplasms | 14.3% |
| 36 | Peritoneal Neoplasms | 14.2% |
| 37 | Bladder Neoplasm | 14.2% |
| 38 | Kidney Neoplasm | 14.2% |
| 39 | Ureteral Neoplasms | 14.2% |
| 40 | Urethral Neoplasms | 14.2% |
| 41 | Bone neoplasms | 14% |
| 42 | Skin Neoplasms | 14% |
| 43 | Hematologic Neoplasms | 14% |
| 44 | Splenic Neoplasms | 13.9% |
| 45 | Genital Neoplasms, Female | 13.8% |
| 46 | Testicular Diseases | 13.6% |
| 47 | Hermaphroditism | 12.9% |
| 48 | Disorders of Sex Development | 12.9% |
| 49 | Nephroblastoma | 12.8% |
| 50 | Hypogonadism | 12.6% |
| 51 | Delayed Puberty | 12.6% |
| 52 | Precocious Puberty | 12.6% |
| 53 | Hypogonadotropic hypogonadism | 12.6% |
| 54 | Testotoxicosis | 12.6% |
| 55 | Tracheal Neoplasms | 12.2% |
| 56 | Paraneoplastic Encephalomyelitis | 12.1% |
| 57 | Mammary Neoplasms, Experimental | 11.9% |
| 58 | Mesoblastic Nephroma | 11.8% |
| 59 | Epididymitis | 11.6% |
| 60 | Penile Diseases | 11.6% |
| 61 | Prostatic Diseases | 11.6% |
| 62 | Spermatic Cord Torsion | 11.6% |
| 63 | Hemospermia | 11.6% |
| 64 | Testicular Hydrocele | 11.6% |
| 65 | Denys-Drash Syndrome | 11.3% |
| 66 | Ovarian Diseases | 10.9% |
| 67 | Esophageal Neoplasms | 10.9% |
| 68 | Renal Cell Carcinoma | 10.9% |
| 69 | Papillary Renal Cell Carcinoma | 10.9% |
| 70 | Adrenal Gland Diseases | 10.8% |
| 71 | Parathyroid Diseases | 10.8% |
| 72 | Thyroid Diseases | 10.8% |
| 73 | Acanthoma | 10.8% |
| 74 | Endocrine Gland Neoplasms | 10.8% |
| 75 | Corpus Luteum Cyst | 10.8% |
| 76 | Ovarian Cysts | 10.8% |
| 77 | Testicular Neoplasms | 10.6% |
| 78 | Kallmann Syndrome | 10.5% |
| 79 | Varicocele | 10.2% |
| 80 | Infertility | 10.1% |
| 81 | Spermatocele | 10.1% |
| 82 | Retroperitoneal Neoplasms | 10% |
| 83 | Carcinoma, Lobular | 9.9% |
| 84 | Klinefelter Syndrome | 9.6% |
| 85 | Bone Diseases, Endocrine | 9.5% |
| 86 | Diabetes Mellitus | 9.4% |
| 87 | Hypospadias | 9.4% |
| 88 | Pituitary Diseases | 9.4% |
| 89 | Hamartoma | 9.4% |
| 90 | Neoplasms, Hormone-Dependent | 9.4% |
| 91 | Neoplasms, Multiple Primary | 9.4% |
| 92 | Paraneoplastic Syndromes | 9.4% |
| 93 | Precancerous Conditions | 9.4% |
| 94 | Neoplasms, Second Primary | 9.4% |
| 95 | Hyperandrogenism | 9.3% |
| 96 | Carcinoma, Endometrioid | 9.1% |
| 97 | Genital Neoplasms, Male | 9.1% |
| 98 | Mouth Neoplasms | 8.9% |
| 99 | Central Nervous System Neoplasms | 8.9% |
| 100 | Vascular Neoplasms | 8.9% |
| 101 | Thymus Neoplasms | 8.9% |
| 102 | Breast Neoplasms, Male | 8.7% |
| 103 | Triple Negative Breast Neoplasms | 8.7% |
| 104 | Urologic Diseases | 8.7% |
| 105 | Gonadal Dysgenesis | 8.6% |
| 106 | Adrenogenital Syndrome | 8.6% |
| 107 | Ovotesticular Disorders of Sex Development | 8.6% |
| 108 | Meningioma | 8.6% |
| 109 | Uterine Neoplasms | 8.5% |
| 110 | Vaginal Neoplasms | 8.5% |
| 111 | Vulvar Neoplasms | 8.5% |
| 112 | Uterine Cancer | 8.5% |
| 113 | Fallopian Tube Neoplasms | 8.4% |
| 114 | Dwarfism | 8.4% |
| 115 | Sexually Transmitted Diseases | 8.3% |
| 116 | Acoustic Neuroma | 8.2% |
| 117 | Cyst | 8.2% |
| 118 | Neoplastic Processes | 8.2% |
| 119 | Neoplastic Syndromes, Hereditary | 8.2% |
| 120 | Pregnancy Complications, Neoplastic | 8.2% |
| 121 | Diabetes Insipidus | 8.2% |
| 122 | Neoplasms, Experimental | 8.2% |
| 123 | Thymoma | 8.1% |
| 124 | Genital Herpes | 8.1% |
| 125 | Gastrointestinal Neoplasms | 7.9% |
| 126 | Liver neoplasms | 7.9% |
| 127 | Uveal Neoplasms | 7.9% |
| 128 | Liver Neoplasms, Experimental | 7.9% |
| 129 | Nose Neoplasms | 7.8% |
| 130 | Sebaceous Gland Neoplasms | 7.8% |
| 131 | Spinal Neoplasms | 7.8% |
| 132 | Bone Marrow Neoplasms | 7.8% |
| 133 | Polycystic Ovary Syndrome | 7.7% |
| 134 | Urogenital Abnormalities | 7.7% |
| 135 | Balanitis | 7.7% |
| 136 | Benign prostatic hypertrophy | 7.7% |
| 137 | Phimosis | 7.7% |
| 138 | Priapism | 7.7% |
| 139 | prostatitis | 7.7% |
| 140 | Prostatic Adenoma | 7.7% |
| 141 | Benign Prostatic Hyperplasia | 7.7% |
| 142 | Prostatic Hypertrophy | 7.7% |
| 143 | Prostatic Hyperplasia | 7.7% |
| 144 | Ovarian Hyperstimulation Syndrome | 7.5% |
| 145 | Tuberous Sclerosis | 7.4% |
| 146 | Palatal Neoplasms | 7.4% |
| 147 | Carcinoma 256, Walker | 7.4% |
| 148 | Leukoplakia, Oral | 7.3% |
| 149 | Congenital Hypothyroidism | 7.3% |
| 150 | Paraneoplastic Cerebellar Degeneration | 7.3% |
| 151 | Neoplasms, Radiation-Induced | 7.3% |
| 152 | Retinoblastoma | 7.1% |
| 153 | Leydig Cell Tumor | 7% |
| 154 | Melanoma, Experimental | 6.9% |
| 155 | Turner Syndrome | 6.9% |
| 156 | Optic Nerve Glioma | 6.8% |
| 157 | Adrenal Cortex Diseases | 6.8% |
| 158 | Euthyroid Sick Syndromes | 6.8% |
| 159 | Goiter | 6.8% |
| 160 | Hyperparathyroidism | 6.8% |
| 161 | Hyperthyroidism | 6.8% |
| 162 | Hyperthyroxinemia | 6.8% |
| 163 | Hypoparathyroidism | 6.8% |
| 164 | Hypothyroidism | 6.8% |
| 165 | Thyroiditis | 6.8% |
| 166 | Secondary hypothyroidism | 6.8% |
| 167 | Primary Hyperthyroidism | 6.8% |
| 168 | Primary Hypothyroidism | 6.8% |
| 169 | Premature Ejaculation | 6.8% |
| 170 | Erectile dysfunction | 6.8% |
| 171 | Trophoblastic Neoplasms | 6.7% |
| 172 | Graves Disease | 6.7% |
| 173 | Carcinoma, Ehrlich Tumor | 6.7% |
| 174 | Dermoid Cyst | 6.7% |
| 175 | Carcinoma, Lewis Lung | 6.7% |
| 176 | Leukemia, Experimental | 6.7% |
| 177 | Diabetic Nephropathy | 6.7% |
| 178 | Hepatocellular Adenoma | 6.6% |
| 179 | Anovulation | 6.6% |
| 180 | Limbic Encephalitis | 6.6% |
| 181 | Oophoritis | 6.6% |
| 182 | Endometrial Neoplasms | 6.6% |
| 183 | Neoplasms, Neuroepithelial | 6.3% |
| 184 | Gliomatosis cerebri | 6.3% |
| 185 | Meningeal Neoplasms | 6.2% |
| 186 | Lambert-Eaton Myasthenic Syndrome | 6.1% |
| 187 | Bladder Exstrophy | 6.1% |
| 188 | Epispadias | 6.1% |
| 189 | Leukemia, Radiation-Induced | 6.1% |
| 190 | Tuberculosis, Renal | 6.1% |
| 191 | Dyspareunia | 6% |
| 192 | Medulloblastoma | 6% |
| 193 | Sarcoma, Experimental | 5.9% |
| 194 | Gonadal Disorders | 5.9% |
| 195 | Empty Sella Syndrome | 5.9% |
| 196 | Hyperpituitarism | 5.9% |
| 197 | Hypopituitarism | 5.9% |
| 198 | Hypophysitis | 5.9% |
| 199 | Neuroectodermal Tumors | 5.9% |
| 200 | Azoospermia | 5.7% |
| 201 | Oligospermia | 5.7% |
| 202 | Impotence, Vasculogenic | 5.7% |
| 203 | Asthenozoospermia | 5.7% |
| 204 | Teratozoospermia | 5.7% |
| 205 | Aspermia | 5.7% |
| 206 | Opsoclonus-Myoclonus Syndrome | 5.7% |
| 207 | Ear Neoplasms | 5.6% |
| 208 | Eyelid Neoplasms | 5.6% |
| 209 | Lung Neoplasms | 5.6% |
| 210 | Pleural Neoplasms | 5.6% |
| 211 | Adenomatous Polyposis Coli | 5.6% |
| 212 | Brain Neoplasms | 5.6% |
| 213 | Salivary Gland Neoplasms | 5.6% |
| 214 | Spinal Cord Neoplasms | 5.6% |
| 215 | Tongue Neoplasms | 5.6% |
| 216 | melanoma | 5.5% |
| 217 | Multicystic Dysplastic Kidney | 5.5% |
| 218 | Anuria | 5.3% |
| 219 | Ureterolithiasis | 5.3% |
| 220 | Nephrolithiasis | 5.3% |
| 221 | Erythroplasia | 5.3% |
| 222 | Follicular cyst | 5.3% |
| 223 | leukemia | 5.3% |
| 224 | Mucocele | 5.3% |
| 225 | Neoplasms, Germ Cell and Embryonal | 5.3% |
| 226 | Neoplasms, Glandular and Epithelial | 5.3% |
| 227 | Pilonidal Cyst | 5.3% |
| 228 | Thyroglossal Cyst | 5.3% |
| 229 | Synovial Cyst | 5.3% |
| 230 | Germ Cell Cancer | 5.3% |
| 231 | Aberrant Crypt Foci | 5.3% |
| 232 | Choriocarcinoma | 5.3% |
| 233 | Diabetic Foot | 5.3% |
| 234 | Gestational Diabetes | 5.3% |
| 235 | Latent Autoimmune Diabetes in Adults | 5.3% |
| 236 | Diabetes Mellitus, Experimental | 5.2% |
| 237 | Myelitis, Transverse | 5.2% |
| 238 | Pharyngeal Neoplasms | 5.1% |
| 239 | Basal Cell Nevus Syndrome | 5.1% |
| 240 | Urinary Bladder Diseases | 5.1% |
| 241 | Kidney Diseases | 5.1% |
| 242 | Ureteral Diseases | 5.1% |
| 243 | Urethral Diseases | 5.1% |
| 244 | Urination Disorders | 5.1% |
| 245 | Urolithiasis | 5.1% |
| 246 | Central Nervous System Cysts | 5% |
| 247 | Bile Duct Neoplasms | 5% |
| 248 | Carcinosarcoma | 5% |
| 249 | gallbladder neoplasm | 5% |
| 250 | Hemangiosarcoma | 5% |
| 251 | Intestinal Neoplasms | 5% |
| 252 | Leukemia L1210 | 5% |
| 253 | Leukemia P388 | 5% |
| 254 | lymphangiosarcoma | 5% |
| 255 | Stomach Neoplasms | 5% |
| 256 | Meningeal Carcinomatosis | 5% |
| 257 | Lymphomatoid Granulomatosis | 5% |
| 258 | Polycythemia Vera | 5% |
| 259 | Genital Diseases, Male | 4.9% |
| 260 | Urinary Bladder Fistula | 4.8% |
| 261 | Cushing Syndrome | 4.8% |
| 262 | Hyperaldosteronism | 4.8% |
| 263 | Hyperparathyroidism, Secondary | 4.8% |
| 264 | Hypoaldosteronism | 4.8% |
| 265 | Thyrotoxicosis | 4.8% |
| 266 | Hyperparathyroidism, Primary | 4.8% |
| 267 | Thyroid Hormone Resistance Syndrome | 4.8% |
| 268 | Adenoma, Acidophil | 4.8% |
| 269 | Ganglioneuroma | 4.8% |
| 270 | Glioma | 4.8% |
| 271 | Malignant Glioma | 4.8% |
| 272 | Leukoplakia | 4.7% |
| 273 | Lymphocele | 4.7% |
| 274 | Pancreatic Cyst | 4.7% |
| 275 | Laryngeal neoplasm | 4.7% |
| 276 | Pituitary Apoplexy | 4.7% |
| 277 | Composite Lymphoma | 4.7% |
| 278 | Barrett Esophagus | 4.6% |
| 279 | Breast Cyst | 4.6% |
| 280 | Histiocytic Disorders, Malignant | 4.6% |
| 281 | Actinic keratosis | 4.6% |
| 282 | Mediastinal Cyst | 4.6% |
| 283 | Neoplasm Invasiveness | 4.6% |
| 284 | Neoplasm Metastasis | 4.6% |
| 285 | Neoplasm Recurrence, Local | 4.6% |
| 286 | Parovarian Cyst | 4.6% |
| 287 | Pericardial Cyst | 4.6% |
| 288 | Thymic Cyst | 4.6% |
| 289 | Carcinogenesis | 4.6% |
| 290 | Myxoid cyst | 4.6% |
| 291 | Metastasis | 4.6% |
| 292 | Bladder neck obstruction | 4.6% |
| 293 | Sarcoma 180 | 4.6% |
| 294 | Kidney Calculi | 4.5% |
| 295 | Urinary tract infection | 4.5% |
| 296 | Ureteral Calculi | 4.5% |
| 297 | Horseshoe Kidney | 4.5% |
| 298 | Bronchial Neoplasms | 4.5% |
| 299 | Multiple Pulmonary Nodules | 4.4% |
| 300 | Leukemia, Plasma Cell | 4.4% |
| 301 | Supratentorial Neoplasms | 4.4% |
| 302 | Carcinoid Tumor | 4.4% |
| 303 | Neurilemmoma | 4.4% |
| 304 | Hutchinson's Melanotic Freckle | 4.4% |
| 305 | Melanoma, Amelanotic | 4.4% |
| 306 | Addison Disease | 4.2% |
| 307 | Diabetic Angiopathies | 4.2% |
| 308 | Autoimmune thyroiditis | 4.2% |
| 309 | Primary Adrenal Insufficiency | 4.2% |
| 310 | Diabetic Neuropathies | 4.2% |
| 311 | Myxedema | 4.2% |
| 312 | Diabetic Amyotrophy | 4.2% |
| 313 | Diabetic Autonomic Neuropathy | 4.2% |
| 314 | Diabetic Cardiomyopathies | 4.2% |
| 315 | Hyperprolactinemia | 4.2% |
| 316 | Basal cell carcinoma | 4.1% |
| 317 | Carcinoma, Papillary | 4.1% |
| 318 | Squamous cell carcinoma | 4.1% |
| 319 | Chondrosarcoma | 4.1% |
| 320 | Craniopharyngioma | 4.1% |
| 321 | Cystadenoma | 4.1% |
| 322 | leiomyosarcoma | 4.1% |
| 323 | liposarcoma | 4.1% |
| 324 | Mesothelioma | 4.1% |
| 325 | synovial sarcoma | 4.1% |
| 326 | Neuroectodermal Tumor, Melanotic | 4.1% |
| 327 | Angiomyolipoma | 4.1% |
| 328 | Clear Cell Sarcoma of Soft Tissue | 4.1% |
| 329 | Alveolar Soft Part Sarcoma | 4.1% |
| 330 | Neuroendocrine Tumors | 4.1% |
| 331 | Sarcoma, Myeloid | 4.1% |
| 332 | Carcinoma, Basal Cell | 4.1% |
| 333 | Lymphoma | 4.1% |
| 334 | Renal Osteodystrophy | 4% |
| 335 | Renal rickets | 4% |
| 336 | Astrocytoma | 4% |
| 337 | Ependymoma | 4% |
| 338 | oligodendroglioma | 4% |
| 339 | Ganglioglioma | 4% |
| 340 | gliosarcoma | 4% |
| 341 | Anaplastic astrocytoma | 4% |
| 342 | Anaplastic Oligodendroglioma | 4% |
| 343 | Hypopharyngeal Neoplasms | 4% |
| 344 | Pleural Effusion, Malignant | 4% |
| 345 | Hypopharyngeal Cancer | 4% |
| 346 | Parotid Neoplasms | 4% |
| 347 | Nasopharyngeal carcinoma | 3.9% |
| 348 | Brain Stem Neoplasms | 3.8% |
| 349 | Malignant Carcinoid Syndrome | 3.8% |
| 350 | Hyperglycemic Hyperosmolar Nonketotic Coma | 3.8% |
| 351 | Hashimoto Disease | 3.8% |
| 352 | Choledochal Cyst | 3.7% |
| 353 | Cystadenocarcinoma | 3.7% |
| 354 | Fibrosarcoma | 3.7% |
| 355 | Osteosarcoma | 3.7% |
| 356 | Mucoepidermoid Carcinoma | 3.7% |
| 357 | Gigantism | 3.7% |
| 358 | Acromegaly | 3.7% |
| 359 | Diabetic Ketoacidosis | 3.7% |
| 360 | Peutz-Jeghers Syndrome | 3.7% |
| 361 | Glioblastoma | 3.6% |
| 362 | Neuroblastoma | 3.6% |
| 363 | Glioblastoma Multiforme | 3.6% |
| 364 | Endometrial Stromal Sarcoma | 3.6% |
| 365 | Pyelocystitis | 3.6% |
| 366 | Chlamydia Infections | 3.6% |
| 367 | Gonorrhea | 3.6% |
| 368 | Cecal Neoplasms | 3.6% |
| 369 | Duodenal Neoplasms | 3.6% |
| 370 | Choroid Plexus Papilloma | 3.6% |
| 371 | Adenofibroma | 3.5% |
| 372 | Fibroadenoma | 3.5% |
| 373 | Malignant Fibrous Histiocytoma | 3.5% |
| 374 | Ganglioneuroblastoma | 3.5% |
| 375 | Tonsillar Neoplasms | 3.5% |
| 376 | Cerebellar Neoplasms | 3.4% |
| 377 | Neurofibrosarcoma | 3.4% |
| 378 | Adenoma | 3.3% |
| 379 | Ameloblastoma | 3.3% |
| 380 | Angiokeratoma | 3.3% |
| 381 | Carcinoma | 3.3% |
| 382 | Chordoma | 3.3% |
| 383 | Hemangioma | 3.3% |
| 384 | hemangiopericytoma | 3.3% |
| 385 | Lymphangioma | 3.3% |
| 386 | Mesenchymoma | 3.3% |
| 387 | Nevus | 3.3% |
| 388 | Teratoma | 3.3% |
| 389 | Hepatoblastoma | 3.3% |
| 390 | Mixed Tumor, Mullerian | 3.3% |
| 391 | Germinoma | 3.3% |
| 392 | Teratocarcinoma | 3.3% |
| 393 | Angiofibroma | 3.3% |
| 394 | Sarcoma | 3.3% |
| 395 | Epithelioma | 3.3% |
| 396 | Cystitis | 3.3% |
| 397 | Hydronephrosis | 3.3% |
| 398 | Hyperoxaluria | 3.3% |
| 399 | Kidney Cortex Necrosis | 3.3% |
| 400 | Kidney Papillary Necrosis | 3.3% |
| 401 | Nephritis | 3.3% |
| 402 | Nephrosclerosis | 3.3% |
| 403 | Nephrosis | 3.3% |
| 404 | Perinephritis | 3.3% |
| 405 | Kidney Failure | 3.3% |
| 406 | Uremia | 3.3% |
| 407 | Ureteral obstruction | 3.3% |
| 408 | Ureterocele | 3.3% |
| 409 | Urethral Obstruction | 3.3% |
| 410 | Urethritis | 3.3% |
| 411 | Vesico-Ureteral Reflux | 3.3% |
| 412 | Urinary Retention | 3.3% |
| 413 | Oxalosis | 3.3% |
| 414 | Renal Insufficiency | 3.3% |
| 415 | Nasopharyngeal Neoplasms | 3.3% |
| 416 | Bowen's Disease | 3.3% |
| 417 | Paraganglioma | 3.3% |
| 418 | Rhabdomyosarcoma | 3.3% |
| 419 | Giant Cell Tumor of Bone | 3.3% |
| 420 | Lymphangioleiomyomatosis | 3.3% |
| 421 | Hydatidiform Mole | 3.3% |
| 422 | Syphilis | 3.3% |
| 423 | Colorectal Neoplasms | 3.3% |
| 424 | Pyelonephritis | 3.3% |
| 425 | Carcinoid Heart Disease | 3.2% |
| 426 | Appendiceal Neoplasms | 3.1% |
| 427 | Colonic Neoplasms | 3.1% |
| 428 | Rectal Neoplasms | 3.1% |
| 429 | Dermatofibrosarcoma | 3.1% |
| 430 | Dermatofibrosarcoma Protuberans | 3.1% |
| 431 | Paranasal Sinus Neoplasms | 3.1% |
| 432 | Glycosuria, Renal | 3% |
| 433 | Diabetic Retinopathy | 3% |
| 434 | Hepatorenal Syndrome | 3% |
| 435 | Lymphogranuloma Venereum | 3% |
| 436 | Bacteriuria | 3% |
| 437 | Glycosuria | 3% |
| 438 | Hematuria | 3% |
| 439 | Renal hypertension | 3% |
| 440 | Oliguria | 3% |
| 441 | Polyuria | 3% |
| 442 | Proteinuria | 3% |
| 443 | Pyuria | 3% |
| 444 | Renal Artery Obstruction | 3% |
| 445 | Renal Artery Stenosis | 3% |
| 446 | Urinary Calculi | 3% |
| 447 | Cystocele | 3% |
| 448 | Nephrocalcinosis | 3% |
| 449 | Urinary Incontinence | 3% |
| 450 | Pancreatic Pseudocyst | 2.9% |
| 451 | Plasmacytoma | 2.9% |
| 452 | Malignant histiocytosis | 2.9% |
| 453 | Lymphatic Metastasis | 2.9% |
| 454 | Neoplasms, Unknown Primary | 2.9% |
| 455 | Leukemic Infiltration | 2.9% |
| 456 | Histiocytic sarcoma | 2.9% |
| 457 | Neoplasm Micrometastasis | 2.9% |
| 458 | Pheochromocytoma | 2.9% |
| 459 | Alveolar rhabdomyosarcoma | 2.9% |
| 460 | Enuresis | 2.7% |
| 461 | Maxillary Sinus Neoplasms | 2.6% |
| 462 | Anus Neoplasms | 2.6% |
| 463 | Sigmoid Neoplasms | 2.6% |
| 464 | Xeroderma Pigmentosum | 2.6% |
| 465 | Hodgkin Disease | 2.6% |
| 466 | Lymphoma, Non-Hodgkin | 2.6% |
| 467 | Glomerulonephritis | 2.5% |
| 468 | Nephritis, Interstitial | 2.5% |
| 469 | Lipoid nephrosis | 2.5% |
| 470 | Nephrotic Syndrome | 2.5% |
| 471 | Pyelitis | 2.5% |
| 472 | Pyonephrosis | 2.5% |
| 473 | Urethral Stenosis | 2.5% |
| 474 | Nephrogenic Diabetes Insipidus | 2.5% |
| 475 | Congenital Nephrogenic Diabetes Insipidus | 2.5% |
| 476 | Acute kidney injury | 2.5% |
| 477 | Urethral stricture | 2.5% |
| 478 | AIDS-Associated Nephropathy | 2.4% |
| 479 | Adenocarcinoma | 2.4% |
| 480 | Carcinoma in Situ | 2.4% |
| 481 | Carcinoma, Transitional Cell | 2.4% |
| 482 | Phyllodes Tumor | 2.4% |
| 483 | Dysgerminoma | 2.4% |
| 484 | Hemangioendothelioma | 2.4% |
| 485 | Lipoma | 2.4% |
| 486 | Myoma | 2.4% |
| 487 | Myxoma | 2.4% |
| 488 | Neuroma | 2.4% |
| 489 | Papilloma | 2.4% |
| 490 | Pseudomyxoma Peritonei | 2.4% |
| 491 | Seminoma | 2.4% |
| 492 | Papillomatosis | 2.4% |
| 493 | Angiolipoma | 2.4% |
| 494 | Myelolipoma | 2.4% |
| 495 | Neoplasms, Bone Tissue | 2.4% |
| 496 | Neoplasms, Fibrous Tissue | 2.4% |
| 497 | Smooth Muscle Tumor | 2.4% |
| 498 | Adenomatosis, Pulmonary | 2.4% |
| 499 | Adenomatous Polyps | 2.4% |
| 500 | Carcinoma, Large Cell | 2.4% |
| 501 | Carcinoma, Small Cell | 2.4% |
| 502 | Desmoplastic Small Round Cell Tumor | 2.4% |
| 503 | Chondroma | 2.4% |
| 504 | Enchondroma | 2.4% |
| 505 | Primary amyloidosis | 2.3% |
| 506 | Azotemia | 2.2% |
| 507 | Albuminuria | 2.2% |
| 508 | Hemoglobinuria | 2.2% |
| 509 | Hypertension, Renovascular | 2.2% |
| 510 | Urge Incontinence | 2.2% |
| 511 | Waterhouse-Friderichsen Syndrome | 2.2% |
| 512 | Leukemia, Myelomonocytic, Chronic | 2.1% |
| 513 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.1% |
| 514 | Balkan Nephropathy | 2.1% |
| 515 | Focal glomerulosclerosis | 2.1% |
| 516 | Kidney Failure, Chronic | 2.1% |
| 517 | Polycystic Kidney Diseases | 2% |
| 518 | Diurnal Enuresis | 2% |
| 519 | Renal Aminoacidurias | 2% |
| 520 | Fanconi Syndrome | 2% |
| 521 | Pseudohypoaldosteronism | 2% |
| 522 | Liddle Syndrome | 2% |
| 523 | Hemolytic-Uremic Syndrome | 2% |
| 524 | Waldenstrom Macroglobulinemia | 1.9% |
| 525 | Multiple Myeloma | 1.9% |
| 526 | Adenoid Cystic Carcinoma | 1.9% |
| 527 | fibroma | 1.9% |
| 528 | Fibromatosis | 1.9% |
| 529 | Osteoblastoma | 1.9% |
| 530 | Osteoma | 1.9% |
| 531 | Rhabdomyoma | 1.9% |
| 532 | Chondromatosis | 1.9% |
| 533 | Adenocarcinoma, Clear Cell | 1.9% |
| 534 | Cholangiocarcinoma | 1.9% |
| 535 | Cervical Intraepithelial Neoplasia | 1.9% |
| 536 | Hemangioblastoma | 1.9% |
| 537 | Lymphoma, Extranodal NK-T-Cell | 1.9% |
| 538 | Glomerulonephritis, Membranoproliferative | 1.9% |
| 539 | Mastocytosis | 1.9% |
| 540 | Sturge-Weber Syndrome | 1.9% |
| 541 | Cell Transformation, Viral | 1.9% |
| 542 | Gastrointestinal Stromal Tumors | 1.9% |
| 543 | Hemangioma, Cavernous | 1.8% |
| 544 | Leukemia, T-Cell | 1.8% |
| 545 | Leukemia, B-Cell | 1.8% |
| 546 | neurofibroma | 1.8% |
| 547 | Lymphoma, Follicular | 1.8% |
| 548 | T-Cell Lymphoma | 1.8% |
| 549 | Mantle cell lymphoma | 1.8% |
| 550 | Renal tubular acidosis | 1.8% |
| 551 | Zollinger-Ellison syndrome | 1.8% |
| 552 | Anti-Glomerular Basement Membrane Disease | 1.7% |
| 553 | Mastocytoma | 1.7% |
| 554 | Fibromatosis, Aggressive | 1.7% |
| 555 | Fibromatosis, Abdominal | 1.7% |
| 556 | Klatskin Tumor | 1.7% |
| 557 | Mastocytosis, Systemic | 1.7% |
| 558 | Lupus Nephritis | 1.7% |
| 559 | Leukemia, Myeloid, Chronic-Phase | 1.7% |
| 560 | Zellweger Syndrome | 1.7% |
| 561 | Polycystic Kidney, Autosomal Dominant | 1.6% |
| 562 | Cystinuria | 1.6% |
| 563 | Atypical Hemolytic Uremic Syndrome | 1.6% |
| 564 | Hyperphosphaturia | 1.5% |
| 565 | Adrenoleukodystrophy | 1.5% |
| 566 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.5% |
| 567 | Leukemia, Large Granular Lymphocytic | 1.5% |
| 568 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.5% |
| 569 | Lymphoma, T-Cell, Cutaneous | 1.5% |
| 570 | Lymphoma, AIDS-Related | 1.5% |
| 571 | Enteropathy-Associated T-Cell Lymphoma | 1.5% |
| 572 | Primary Effusion Lymphoma | 1.5% |
| 573 | Dupuytren Contracture | 1.3% |
| 574 | Urticaria Pigmentosa | 1.3% |
| 575 | Mycosis Fungoides | 1.3% |
| 576 | Lymphomatoid Papulosis | 1.3% |
| 577 | Plasmablastic lymphoma | 1.3% |
| 578 | Burkitt Lymphoma | 1.2% |
| 579 | Sezary Syndrome | 1% |
| 580 | Radicular Cyst | 1% |
| 581 | Familial Hypophosphatemic Rickets | 0.9% |